Vericel Corp Sustainability Reports
Vericel Corporation develops, manufactures, and markets patient-specific expanded cellular therapies and specialty biologics. Its primary products focus on the sports medicine and severe burn care fields.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 54930076YM3PLTDR4B91
FIGI: BBG001S6X9M3
9 reports from 2014 to 2025